TY - JOUR AU - Seemungal, T. A. AU - Donaldson, G. C. AU - Paul, E. A. AU - Bestall, J. C. AU - Jeffries, D. J. AU - Wedzicha, J. A. PY - 1998 DA - 1998// TI - Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease JO - Am J Respir Crit Care Med VL - 157 UR - https://doi.org/10.1164/ajrccm.157.5.9709032 DO - 10.1164/ajrccm.157.5.9709032 ID - Seemungal1998 ER - TY - JOUR AU - Doll, H. AU - Miravitlles, M. PY - 2005 DA - 2005// TI - Health-related QOL in acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease: a review of the literature JO - Pharmacoeconomics VL - 23 UR - https://doi.org/10.2165/00019053-200523040-00005 DO - 10.2165/00019053-200523040-00005 ID - Doll2005 ER - TY - JOUR AU - Seemungal, T. A. AU - Donaldson, G. C. AU - Bhowmik, A. AU - Jeffries, D. J. AU - Wedzicha, J. A. PY - 2000 DA - 2000// TI - Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease JO - Am J Respir Crit Care Med VL - 161 UR - https://doi.org/10.1164/ajrccm.161.5.9908022 DO - 10.1164/ajrccm.161.5.9908022 ID - Seemungal2000 ER - TY - JOUR AU - Donaldson, G. C. AU - Seemungal, T. A. AU - Bhowmik, A. AU - Wedzicha, J. A. PY - 2002 DA - 2002// TI - Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease JO - Thorax VL - 57 UR - https://doi.org/10.1136/thorax.57.10.847 DO - 10.1136/thorax.57.10.847 ID - Donaldson2002 ER - TY - JOUR AU - Kanner, R. E. AU - Anthonisen, N. R. AU - Connett, J. E. PY - 2001 DA - 2001// TI - Lower respiratory illnesses promote FEV1 decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study JO - Am J Respir Crit Care Med VL - 164 UR - https://doi.org/10.1164/ajrccm.164.3.2010017 DO - 10.1164/ajrccm.164.3.2010017 ID - Kanner2001 ER - TY - JOUR AU - Qureshi, H. AU - Sharafkhaneh, A. AU - Hanania, N. A. PY - 2014 DA - 2014// TI - Chronic obstructive pulmonary disease exacerbations: latest evidence and clinical implications JO - Ther Adv Chronic Dis VL - 5 UR - https://doi.org/10.1177/2040622314532862 DO - 10.1177/2040622314532862 ID - Qureshi2014 ER - TY - JOUR AU - Soler-Cataluña, J. J. AU - Martínez-García, M. A. AU - Román Sánchez, P. AU - Salcedo, E. AU - Navarro, M. AU - Ochando, R. PY - 2005 DA - 2005// TI - Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease JO - Thorax VL - 60 UR - https://doi.org/10.1136/thx.2005.040527 DO - 10.1136/thx.2005.040527 ID - Soler-Cataluña2005 ER - TY - JOUR AU - Miravitlles, M. AU - Murio, C. AU - Guerrero, T. AU - Gisbert, R. PY - 2003 DA - 2003// TI - Costs of chronic bronchitis and COPD: a 1-year follow-up study JO - Chest VL - 123 UR - https://doi.org/10.1378/chest.123.3.784 DO - 10.1378/chest.123.3.784 ID - Miravitlles2003 ER - TY - STD TI - Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease, GOLD Executive Summary. Am J Respir Crit Care Med. 2013;187: 347-365. ID - ref9 ER - TY - JOUR AU - Bafadhel, M. AU - McKenna, S. AU - Terry, S. AU - Mistry, V. AU - Reid, C. AU - Haldar, P. AU - McCormick, M. AU - Haldar, K. AU - Kebadze, T. AU - Duvoix, A. PY - 2011 DA - 2011// TI - Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers JO - Am J Respir Crit Care Med VL - 184 UR - https://doi.org/10.1164/rccm.201104-0597OC DO - 10.1164/rccm.201104-0597OC ID - Bafadhel2011 ER - TY - JOUR AU - Aaron, S. D. PY - 2014 DA - 2014// TI - Management and prevention of exacerbations of COPD JO - BMJ VL - 349 UR - https://doi.org/10.1136/bmj.g5237 DO - 10.1136/bmj.g5237 ID - Aaron2014 ER - TY - JOUR AU - Aaron, S. D. AU - Fergusson, D. AU - Marks, G. B. AU - Suissa, S. AU - Vandemheen, K. L. AU - Doucette, S. AU - Maltais, F. AU - Bourbeau, J. F. AU - Goldstein, R. S. AU - Balter, M. PY - 2008 DA - 2008// TI - Counting, analysing and reporting exacerbations of COPD in randomised controlled trials JO - Thorax VL - 63 UR - https://doi.org/10.1136/thx.2007.082636 DO - 10.1136/thx.2007.082636 ID - Aaron2008 ER - TY - JOUR AU - Calverley, P. M. AU - Anderson, J. A. AU - Celli, B. AU - Ferguson, G. T. AU - Jenkins, C. AU - Jones, P. W. AU - Yates, J. C. AU - Vestbo, J. PY - 2007 DA - 2007// TI - Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease JO - N Engl J Med VL - 356 UR - https://doi.org/10.1056/NEJMoa063070 DO - 10.1056/NEJMoa063070 ID - Calverley2007 ER - TY - JOUR AU - Hurst, J. R. AU - Vestbo, J. AU - Anzueto, A. AU - Locantore, N. AU - Müllerova, H. AU - Tal-Singer, R. AU - Miller, B. AU - Lomas, D. A. AU - Agusti, A. AU - MacNee, W. PY - 2010 DA - 2010// TI - Susceptibility to exacerbation in chronic obstructive pulmonary disease JO - N Engl J Med VL - 363 UR - https://doi.org/10.1056/NEJMoa0909883 DO - 10.1056/NEJMoa0909883 ID - Hurst2010 ER - TY - JOUR AU - Tashkin, D. P. AU - Celli, B. AU - Senn, S. AU - Burkhart, D. AU - Kesten, S. AU - Menjoge, S. AU - Decramer, M. PY - 2008 DA - 2008// TI - A 4-year trial of tiotropium in chronic obstructive pulmonary disease JO - N Engl J Med VL - 359 UR - https://doi.org/10.1056/NEJMoa0805800 DO - 10.1056/NEJMoa0805800 ID - Tashkin2008 ER - TY - JOUR AU - Wise, R. A. AU - Anzueto, A. AU - Cotton, D. AU - Dahl, R. AU - Devins, T. AU - Disse, B. AU - Dusser, D. AU - Joseph, E. AU - Kattenbeck, S. AU - Koenen-Bergmann, M. PY - 2013 DA - 2013// TI - Tiotropium Respimat inhaler and the risk of death in COPD JO - N Engl J Med VL - 369 UR - https://doi.org/10.1056/NEJMoa1303342 DO - 10.1056/NEJMoa1303342 ID - Wise2013 ER - TY - JOUR AU - Cazzola, M. AU - MacNee, W. AU - Martinez, F. J. AU - Rabe, K. F. AU - Franciosi, L. G. AU - Barnes, P. J. AU - Brusasco, V. AU - Burge, P. S. AU - Calverley, P. M. AU - Celli, B. R. PY - 2008 DA - 2008// TI - Outcomes for COPD pharmacological trials: from lung function to biomarkers JO - Eur Respir J VL - 31 UR - https://doi.org/10.1183/09031936.00099306 DO - 10.1183/09031936.00099306 ID - Cazzola2008 ER - TY - JOUR AU - Langsetmo, L. AU - Platt, R. W. AU - Ernst, P. AU - Bourbeau, J. PY - 2008 DA - 2008// TI - Underreporting exacerbation of chronic obstructive pulmonary disease in a longitudinal cohort JO - Am J Respir Crit Care Med VL - 177 UR - https://doi.org/10.1164/rccm.200708-1290OC DO - 10.1164/rccm.200708-1290OC ID - Langsetmo2008 ER - TY - JOUR AU - Xu, W. AU - Collet, J. P. AU - Shapiro, S. AU - Lin, Y. AU - Yang, T. AU - Wang, C. AU - Bourbeau, J. PY - 2010 DA - 2010// TI - Negative impacts of unreported COPD exacerbations on health-related quality of life at 1 year JO - Eur Respir J VL - 35 UR - https://doi.org/10.1183/09031936.00079409 DO - 10.1183/09031936.00079409 ID - Xu2010 ER - TY - JOUR AU - Ball, P. PY - 1995 DA - 1995// TI - Epidemiology and treatment of chronic bronchitis and its exacerbations JO - Chest VL - 108 UR - https://doi.org/10.1378/chest.108.2_Supplement.43S DO - 10.1378/chest.108.2_Supplement.43S ID - Ball1995 ER - TY - JOUR AU - Sapey, E. AU - Stockley, R. A. PY - 2006 DA - 2006// TI - COPD exacerbations.2: aetiology JO - Thorax VL - 61 UR - https://doi.org/10.1136/thx.2005.041822 DO - 10.1136/thx.2005.041822 ID - Sapey2006 ER - TY - JOUR AU - Wedzicha, J. A. AU - Seemungal, T. A. PY - 2007 DA - 2007// TI - COPD exacerbations: defining their cause and prevention JO - Lancet VL - 370 UR - https://doi.org/10.1016/S0140-6736(07)61382-8 DO - 10.1016/S0140-6736(07)61382-8 ID - Wedzicha2007 ER - TY - JOUR AU - Donaldson, G. C. AU - Wedzicha, J. A. PY - 2006 DA - 2006// TI - COPD exacerbations.1: Epidemiology JO - Thorax VL - 61 UR - https://doi.org/10.1136/thx.2005.041806 DO - 10.1136/thx.2005.041806 ID - Donaldson2006 ER - TY - JOUR AU - Anderson, H. R. AU - Spix, C. AU - Medina, S. AU - Schouten, J. P. AU - Castellsague, J. AU - Rossi, G. AU - Zmirou, D. AU - Touloumi, G. AU - Wojtyniak, B. AU - Ponka, A. PY - 1997 DA - 1997// TI - Air pollution and daily admissions for chronic obstructive pulmonary disease in 6 European cities: results from the APHEA project JO - Eur Respir J VL - 10 UR - https://doi.org/10.1183/09031936.97.10051064 DO - 10.1183/09031936.97.10051064 ID - Anderson1997 ER - TY - JOUR AU - Ramsey, S. D. AU - Hobbs, F. D. PY - 2006 DA - 2006// TI - Chronic obstructive pulmonary disease, risk factors, and outcome trials: comparisons with cardiovascular disease JO - Proc Am Thorac Soc VL - 3 UR - https://doi.org/10.1513/pats.200603-094SS DO - 10.1513/pats.200603-094SS ID - Ramsey2006 ER - TY - JOUR AU - Evensen, A. E. PY - 2010 DA - 2010// TI - Management of COPD exacerbations JO - Am Fam Physician VL - 81 ID - Evensen2010 ER - TY - JOUR AU - Moy, M. L. AU - Teylan, M. AU - Weston, N. A. AU - Gagnon, D. R. AU - Garshick, E. PY - 2013 DA - 2013// TI - Daily step count predicts acute exacerbations in a US cohort with COPD JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0060400 DO - 10.1371/journal.pone.0060400 ID - Moy2013 ER - TY - JOUR AU - Burgel, P. R. AU - Nesme-Meyer, P. AU - Chanez, P. AU - Caillaud, D. AU - Carré, P. AU - Perez, T. AU - Roche, N. PY - 2009 DA - 2009// TI - Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects JO - Chest VL - 135 UR - https://doi.org/10.1378/chest.08-2062 DO - 10.1378/chest.08-2062 ID - Burgel2009 ER - TY - JOUR AU - Kim, V. AU - Criner, G. J. PY - 2015 DA - 2015// TI - The chronic bronchitis phenotype in chronic obstructive pulmonary disease: features and implications JO - Curr Opin Pulm Med VL - 21 UR - https://doi.org/10.1097/MCP.0000000000000145 DO - 10.1097/MCP.0000000000000145 ID - Kim2015 ER - TY - JOUR AU - Miravitlles, M. PY - 2011 DA - 2011// TI - Cough and sputum production as risk factors for poor outcomes in patients with COPD JO - Respir Med VL - 105 UR - https://doi.org/10.1016/j.rmed.2011.02.003 DO - 10.1016/j.rmed.2011.02.003 ID - Miravitlles2011 ER - TY - JOUR AU - Oh, Y. M. AU - Sheen, S. S. AU - Park, J. H. AU - Jin, U. R. AU - Yoo, J. W. AU - Seo, J. B. AU - Yoo, K. H. AU - Lee, J. H. AU - Kim, T. H. AU - Lim, S. Y. PY - 2014 DA - 2014// TI - Emphysematous phenotype is an independent predictor for frequent exacerbation of COPD JO - Int J Tuberc Lung Dis VL - 18 UR - https://doi.org/10.5588/ijtld.14.0205 DO - 10.5588/ijtld.14.0205 ID - Oh2014 ER - TY - JOUR AU - Han, M. K. AU - Agusti, A. AU - Calverley, P. M. AU - Celli, B. R. AU - Criner, G. AU - Curtis, J. L. AU - Fabbri, L. M. AU - Goldin, J. G. AU - Jones, P. W. AU - MacNee, W. PY - 2010 DA - 2010// TI - Chronic obstructive pulmonary disease phenotypes: the future of COPD JO - Am J Respir Crit Care Med VL - 182 UR - https://doi.org/10.1164/rccm.200912-1843CC DO - 10.1164/rccm.200912-1843CC ID - Han2010 ER - TY - JOUR AU - Miravitlles, M. AU - Soler-Cataluña, J. J. AU - Calle, M. AU - Molina, J. AU - Almagro, P. AU - Quintano, J. A. AU - Riesco, J. A. AU - Trigueros, J. A. AU - Piñera, P. AU - Simón, A. PY - 2014 DA - 2014// TI - Spanish guideline for COPD (GesEPOC). Update 2014 JO - Arch Bronconeumol VL - 50 ID - Miravitlles2014 ER - TY - JOUR AU - Kankaanranta, H. AU - Harju, T. AU - Kilpelainen, M. AU - Mazur, W. AU - Lehto, J. T. AU - Katajisto, M. AU - Peisa, T. AU - Meinander, T. AU - Lehtimäki, L. PY - 2015 DA - 2015// TI - Diagnosis and Pharmacotherapy of Stable Chronic Obstructive Pulmonary Disease: The Finnish Guidelines JO - Basic Clin Pharmacol Toxicol VL - 116 UR - https://doi.org/10.1111/bcpt.12366 DO - 10.1111/bcpt.12366 ID - Kankaanranta2015 ER - TY - JOUR AU - Koblizek, V. AU - Chlumsky, J. AU - Zindr, V. AU - Neumannova, K. AU - Zatloukal, J. AU - Zak, J. AU - Sedlak, V. AU - Kocianova, J. AU - Zatloukal, J. AU - Hejduk, K. AU - Pracharova, S. PY - 2013 DA - 2013// TI - Chronic Obstructive Pulmonary Disease: official diagnosis and treatment guidelines of the Czech Pneumological and Phthisiological Society; a novel phenotypic approach to COPD with patient-oriented care JO - Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub VL - 157 ID - Koblizek2013 ER - TY - JOUR AU - Khan, J. H. AU - Lababidi, H. M. AU - Al-Moamary, M. S. AU - Zeitouni, M. O. AU - Al-Jahdali, H. H. AU - Al-Amoudi, O. S. AU - Wali, S. O. AU - Idrees, M. M. AU - Al-Shimemri, A. A. AU - Al Ghobain, M. O. PY - 2014 DA - 2014// TI - The Saudi Guidelines for the Diagnosis and Management of COPD JO - Ann Thorac Med VL - 9 UR - https://doi.org/10.4103/1817-1737.128843 DO - 10.4103/1817-1737.128843 ID - Khan2014 ER - TY - JOUR AU - Gupta, D. AU - Agarwal, R. AU - Aggarwal, A. N. AU - Maturu, V. N. AU - Dhooria, S. AU - Prasad, K. T. AU - Sehgal, I. S. AU - Yenge, L. B. AU - Jindal, A. AU - Singh, N. PY - 2013 DA - 2013// TI - Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations JO - Lung India VL - 30 UR - https://doi.org/10.4103/0970-2113.116248 DO - 10.4103/0970-2113.116248 ID - Gupta2013 ER - TY - JOUR AU - Soler Cataluña, J. J. AU - Piñer Salmerón, P. AU - Trigueros, J. A. AU - Calle, M. AU - Almagro, P. AU - Molina, J. AU - Quintano, J. A. AU - Riesco, J. A. AU - Simón, A. AU - Soriano, J. B. PY - 2013 DA - 2013// TI - Spanish COPD guidelines (GesEPOC): hospital diagnosis and treatment of COPD exacerbation JO - Emergencias VL - 25 ID - Soler Cataluña2013 ER - TY - JOUR AU - Miravitlles, M. AU - Soriano, J. B. AU - Ancochea, J. AU - Muñoz, L. AU - Duran-Tauleria, E. AU - Sanchez, G. AU - Sobradillo, V. AU - García-Río, F. PY - 2013 DA - 2013// TI - Characterisation of the overlap COPD-asthma phenotype. Focus on physical activity and health status JO - Respir Med VL - 107 UR - https://doi.org/10.1016/j.rmed.2013.03.007 DO - 10.1016/j.rmed.2013.03.007 ID - Miravitlles2013 ER - TY - JOUR AU - Hardin, M. AU - Silverman, E. K. AU - Barr, R. G. AU - Hansel, N. N. AU - Schroeder, J. D. AU - Make, B. J. AU - Crapo, J. D. AU - Hersh, C. P. PY - 2011 DA - 2011// TI - The clinical features of the overlap between COPD and asthma JO - Respir Res VL - 12 UR - https://doi.org/10.1186/1465-9921-12-127 DO - 10.1186/1465-9921-12-127 ID - Hardin2011 ER - TY - JOUR AU - Menezes, A. M. AU - Montes de Oca, M. AU - Pérez-Padilla, R. AU - Nadeau, G. AU - Wehrmeister, F. C. AU - Lopez-Varela, M. V. AU - Muiño, A. AU - Jardim, J. R. AU - Valdivia, G. AU - Tálamo, C. PY - 2014 DA - 2014// TI - Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma JO - Chest VL - 145 UR - https://doi.org/10.1378/chest.13-0622 DO - 10.1378/chest.13-0622 ID - Menezes2014 ER - TY - JOUR AU - Agusti, A. AU - Hurd, S. AU - Jones, P. AU - Fabbri, L. M. AU - Martinez, F. AU - Vogelmeier, C. AU - Vestbo, J. AU - Rodriguez-Roisin, R. PY - 2013 DA - 2013// TI - FAQs about the GOLD 2011 assessment proposal of COPD: a comparative analysis of four different cohorts JO - Eur Respir J VL - 42 UR - https://doi.org/10.1183/09031936.00036513 DO - 10.1183/09031936.00036513 ID - Agusti2013 ER - TY - JOUR AU - Han, M. K. AU - Muellerova, H. AU - Curran-Everett, D. AU - Dransfield, M. T. AU - Washko, G. R. AU - Regan, E. A. AU - Bowler, R. P. AU - Beaty, T. H. AU - Hokanson, J. E. AU - Lynch, D. A. PY - 2013 DA - 2013// TI - GOLD 2011 disease severity classification in COPDGene: a prospective cohort study JO - Lancet Respir Med VL - 1 UR - https://doi.org/10.1016/S2213-2600(12)70044-9 DO - 10.1016/S2213-2600(12)70044-9 ID - Han2013 ER - TY - JOUR AU - Bhowmik, A. AU - Seemungal, T. A. AU - Sapsford, R. J. AU - Wedzicha, J. A. PY - 2000 DA - 2000// TI - Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations JO - Thorax VL - 55 UR - https://doi.org/10.1136/thorax.55.2.114 DO - 10.1136/thorax.55.2.114 ID - Bhowmik2000 ER - TY - JOUR AU - Saetta, M. AU - Stefano, A. AU - Maestrelli, P. AU - Turato, G. AU - Ruggieri, M. P. AU - Roggeri, A. AU - Calcagni, P. AU - Mapp, C. E. AU - Ciaccia, A. AU - Fabbri, L. M. PY - 1994 DA - 1994// TI - Airway eosinophilia in chronic bronchitis during exacerbations JO - Am J Respir Crit Care Med VL - 150 UR - https://doi.org/10.1164/ajrccm.150.6.7952628 DO - 10.1164/ajrccm.150.6.7952628 ID - Saetta1994 ER - TY - JOUR AU - Hurst, J. R. PY - 2011 DA - 2011// TI - Exacerbation phenotyping in chronic obstructive pulmonary disease JO - Am J Respir Crit Care Med VL - 184 UR - https://doi.org/10.1164/rccm.201106-1136ED DO - 10.1164/rccm.201106-1136ED ID - Hurst2011 ER - TY - JOUR AU - George, L. AU - Brightling, C. E. PY - 2016 DA - 2016// TI - Eosinophilic airway inflammation: role in asthma and chronic obstructive pulmonary disease JO - Ther Adv Chronic Dis VL - 7 UR - https://doi.org/10.1177/2040622315609251 DO - 10.1177/2040622315609251 ID - George2016 ER - TY - JOUR AU - Kitaguchi, Y. AU - Komatsu, Y. AU - Fujimoto, K. AU - Hanaoka, M. AU - Kubo, K. PY - 2012 DA - 2012// TI - Sputum eosinophilia can predict responsiveness to inhaled corticosteroid treatment in patients with overlap syndrome of COPD and asthma JO - Int J Chron Obstruct Pulmon Dis VL - 7 ID - Kitaguchi2012 ER - TY - JOUR AU - Papi, A. AU - Romagnoli, M. AU - Baraldo, S. AU - Braccioni, F. AU - Guzzinati, I. AU - Saetta, M. AU - Ciaccia, A. AU - Fabbri, L. M. PY - 2000 DA - 2000// TI - Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease JO - Am J Respir Crit Care Med VL - 162 UR - https://doi.org/10.1164/ajrccm.162.5.9910112 DO - 10.1164/ajrccm.162.5.9910112 ID - Papi2000 ER - TY - JOUR AU - Montuschi, P. AU - Malerba, M. AU - Santini, G. AU - Miravitlles, M. PY - 2014 DA - 2014// TI - Pharmacological treatment of chronic obstructive pulmonary disease: from evidence-based medicine to phenotyping JO - Drug Discov Today VL - 19 UR - https://doi.org/10.1016/j.drudis.2014.08.004 DO - 10.1016/j.drudis.2014.08.004 ID - Montuschi2014 ER - TY - JOUR AU - Iwamoto, H. AU - Gao, J. AU - Koskela, J. AU - Kinnula, V. AU - Kobayashi, H. AU - Laitinen, T. AU - Mazur, W. PY - 2014 DA - 2014// TI - Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlap JO - Eur Respir J VL - 43 UR - https://doi.org/10.1183/09031936.00024313 DO - 10.1183/09031936.00024313 ID - Iwamoto2014 ER - TY - JOUR AU - Slats, A. AU - Taube, C. PY - 2016 DA - 2016// TI - Asthma and chronic obstructive pulmonary disease overlap: asthmatic chronic obstructive pulmonary disease or chronic obstructive asthma? JO - Ther Adv Respir Dis VL - 10 UR - https://doi.org/10.1177/1753465815617082 DO - 10.1177/1753465815617082 ID - Slats2016 ER - TY - STD TI - Mulhall P, Criner G. Non-pharmacological treatments for COPD. Respirology. 2016;21:791-809. ID - ref53 ER - TY - JOUR AU - Spruit, M. A. AU - Singh, S. J. AU - Garvey, C. AU - ZuWallack, R. AU - Nici, L. AU - Rochester, C. AU - Hill, K. AU - Holland, A. E. AU - Lareau, S. C. AU - Man, W. D. PY - 2013 DA - 2013// TI - An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation JO - Am J Respir Crit Care Med VL - 188 UR - https://doi.org/10.1164/rccm.201309-1634ST DO - 10.1164/rccm.201309-1634ST ID - Spruit2013 ER - TY - STD TI - Puhan MA, Gimeno-Santos E, Scharplatz M, Troosters T, Walters EH, Steurer J. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. 2011, Issue 10. Art. No.: CD005305. ID - ref55 ER - TY - JOUR AU - Zysman, M. AU - Patout, M. AU - Miravitlles, M. AU - Molen, T. AU - Lokke, A. AU - Hausen, T. AU - Didier, A. AU - Cuvelier, A. AU - Roche, N. PY - 2014 DA - 2014// TI - COPD and perception of the new GOLD document in Europe. Workshop from the Societe de pneumologie de langue francaise (SPLF) JO - Rev Mal Respir VL - 31 UR - https://doi.org/10.1016/j.rmr.2014.02.014 DO - 10.1016/j.rmr.2014.02.014 ID - Zysman2014 ER - TY - JOUR AU - Miravitlles, M. AU - Calle, M. AU - Soler-Cataluña, J. J. PY - 2012 DA - 2012// TI - Clinical phenotypes of COPD: identification, definition and implications for guidelines JO - Arch Bronconeumol VL - 48 ID - Miravitlles2012 ER - TY - JOUR AU - Goh, F. AU - Shaw, J. G. AU - Savarimuthu Francis, S. M. AU - Vaughan, A. AU - Morrison, L. AU - Relan, V. AU - Marshall, H. M. AU - Dent, A. G. AU - O’Hare, P. E. AU - Hsiao, A. PY - 2013 DA - 2013// TI - Personalizing and targeting therapy for COPD: the role of molecular and clinical biomarkers JO - Expert Rev Respir Med VL - 7 UR - https://doi.org/10.1586/17476348.2013.842468 DO - 10.1586/17476348.2013.842468 ID - Goh2013 ER - TY - JOUR AU - Miravitlles, M. AU - Soler-Cataluña, J. J. AU - Calle, M. AU - Soriano, J. B. PY - 2013 DA - 2013// TI - Treatment of COPD by clinical phenotypes: putting old evidence into clinical practice JO - Eur Respir J VL - 41 UR - https://doi.org/10.1183/09031936.00118912 DO - 10.1183/09031936.00118912 ID - Miravitlles2013 ER - TY - JOUR AU - Vogelmeier, C. AU - Hederer, B. AU - Glaab, T. AU - Schmidt, H. AU - Rutten-van Mölken, M. P. AU - Beeh, K. M. AU - Rabe, K. F. AU - Fabbri, L. M. PY - 2011 DA - 2011// TI - Tiotropium versus salmeterol for the prevention of exacerbations of COPD JO - N Engl J Med VL - 364 UR - https://doi.org/10.1056/NEJMoa1008378 DO - 10.1056/NEJMoa1008378 ID - Vogelmeier2011 ER - TY - JOUR AU - Wedzicha, J. A. AU - Calverley, P. M. AU - Seemungal, T. A. AU - Hagan, G. AU - Ansari, Z. AU - Stockley, R. A. PY - 2008 DA - 2008// TI - The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide JO - Am J Respir Crit Care Med VL - 177 UR - https://doi.org/10.1164/rccm.200707-973OC DO - 10.1164/rccm.200707-973OC ID - Wedzicha2008 ER - TY - JOUR AU - Wedzicha, J. A. AU - Decramer, M. AU - Ficker, J. H. AU - Niewoehner, D. E. AU - Sandstöm, T. AU - Taylor, A. F. AU - D’Andrea, P. AU - Arrasate, C. AU - Chen, H. AU - Banerji, D. PY - 2013 DA - 2013// TI - Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group study JO - Lancet Respir Med VL - 1 UR - https://doi.org/10.1016/S2213-2600(13)70052-3 DO - 10.1016/S2213-2600(13)70052-3 ID - Wedzicha2013 ER - TY - JOUR AU - Decramer, M. L. AU - Chapman, K. R. AU - Dahl, R. AU - Frith, P. AU - Devouassoux, G. AU - Fritscher, C. AU - Cameron, R. AU - Shoaib, M. AU - Lawrence, D. AU - Young, D. PY - 2013 DA - 2013// TI - Once-daily indacaterol versus tiotropium for patients with severe chronic obstructive pulmonary disease (INVIGORATE): a randomised, blinded, parallel-group study JO - Lancet Respir Med VL - 1 UR - https://doi.org/10.1016/S2213-2600(13)70158-9 DO - 10.1016/S2213-2600(13)70158-9 ID - Decramer2013 ER - TY - JOUR AU - Aaron, S. D. AU - Vandemheen, K. L. AU - Fergusson, D. AU - Maltais, F. AU - Bourbeau, J. AU - Goldstein, R. AU - Balter, M. AU - O’Donnell, D. AU - McIvor, A. AU - Sharma, S. PY - 2007 DA - 2007// TI - Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial JO - Ann Intern Med VL - 146 UR - https://doi.org/10.7326/0003-4819-146-8-200704170-00152 DO - 10.7326/0003-4819-146-8-200704170-00152 ID - Aaron2007 ER - TY - JOUR AU - Calverley, P. AU - Pauwels, R. AU - Vestbo, J. AU - Jones, P. AU - Pride, N. AU - Gulsvik, A. AU - Anderson, J. AU - Maden, C. PY - 2003 DA - 2003// TI - Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial JO - Lancet VL - 361 UR - https://doi.org/10.1016/S0140-6736(03)12459-2 DO - 10.1016/S0140-6736(03)12459-2 ID - Calverley2003 ER - TY - JOUR AU - Wedzicha, J. A. AU - Buhl, R. AU - Lawrence, D. AU - Young, D. PY - 2015 DA - 2015// TI - Monotherapy with indacaterol once daily reduces the rate of exacerbations in patients with moderate-to-severe COPD: Post-hoc pooled analysis of 6 months data from three large phase III trials JO - Respir Med VL - 109 UR - https://doi.org/10.1016/j.rmed.2014.10.011 DO - 10.1016/j.rmed.2014.10.011 ID - Wedzicha2015 ER - TY - JOUR AU - Karner, C. AU - Chong, J. AU - Poole, P. PY - 2014 DA - 2014// TI - Tiotropium versus placebo for chronic obstructive pulmonary disease JO - Cochrane Database Syst Rev VL - 7 ID - Karner2014 ER - TY - JOUR AU - D’Urzo, A. AU - Ferguson, G. T. AU - Noord, J. A. AU - Hirata, K. AU - Martin, C. AU - Horton, R. AU - Lu, Y. AU - Banerji, D. AU - Overend, T. PY - 2011 DA - 2011// TI - Efficacy and safety of once-daily NVA237 in patients with moderate-to-severe COPD: the GLOW1 trial JO - Respir Res VL - 12 UR - https://doi.org/10.1186/1465-9921-12-156 DO - 10.1186/1465-9921-12-156 ID - D’Urzo2011 ER - TY - JOUR AU - Kerwin, E. AU - Hébert, J. AU - Gallagher, N. AU - Martin, C. AU - Overend, T. AU - Alagappan, V. K. AU - Lu, Y. AU - Banerji, D. PY - 2012 DA - 2012// TI - Efficacy and safety of NVA237 versus placebo and tiotropium in patients with COPD: the GLOW2 study JO - Eur Respir J VL - 40 UR - https://doi.org/10.1183/09031936.00040712 DO - 10.1183/09031936.00040712 ID - Kerwin2012 ER - TY - JOUR AU - Jones, P. W. AU - Rennard, S. I. AU - Agusti, A. AU - Chanez, P. AU - Magnussen, H. AU - Fabbri, L. AU - Donohue, J. F. AU - Bateman, E. D. AU - Gross, N. J. AU - Lamarca, R. PY - 2011 DA - 2011// TI - Efficacy and safety of once-daily aclidinium in chronic obstructive pulmonary disease JO - Respir Res VL - 12 UR - https://doi.org/10.1186/1465-9921-12-55 DO - 10.1186/1465-9921-12-55 ID - Jones2011 ER - TY - JOUR AU - Rabe, K. F. AU - Fabbri, L. M. AU - Israel, E. AU - Kogler, H. AU - Riemann, K. AU - Schmidt, H. AU - Glaab, T. AU - Vogelmeier, C. F. PY - 2014 DA - 2014// TI - Effect of ADRB2 polymorphisms on the efficacy of salmeterol and tiotropium in preventing COPD exacerbations: a prespecified substudy of the POET-COPD trial JO - Lancet Respir Med VL - 2 UR - https://doi.org/10.1016/S2213-2600(13)70248-0 DO - 10.1016/S2213-2600(13)70248-0 ID - Rabe2014 ER - TY - JOUR AU - Bateman, E. D. AU - Chapman, K. R. AU - Singh, D. AU - D’Urzo, A. D. AU - Molins, E. AU - Leselbaum, A. AU - Gil, E. G. PY - 2015 DA - 2015// TI - Aclidinium bromide and formoterol fumarate as a fixed-dose combination in COPD: pooled analysis of symptoms and exacerbations from two six-month, multicentre, randomised studies (ACLIFORM and AUGMENT) JO - Respir Res VL - 16 UR - https://doi.org/10.1186/s12931-015-0250-2 DO - 10.1186/s12931-015-0250-2 ID - Bateman2015 ER - TY - JOUR AU - Zhong, N. AU - Wang, C. AU - Zhou, X. AU - Zhang, N. AU - Humphries, M. AU - Wang, C. AU - Thach, C. AU - Patalano, F. AU - Banerji, D. PY - 2015 DA - 2015// TI - LANTERN: a randomized study of QVA149 versus salmeterol/fluticasone combination in patients with COPD JO - Int J COPD VL - 10 ID - Zhong2015 ER - TY - STD TI - Wedzicha JA, Banerji D, Chapman KR, Vestbo J, Roche N, Ayers RT, Thach C, Fogel R, Patalano F, Vogelmeier C. Indacaterol-glycopyrronium versus salmeterol-fluticasone for COPD. N Engl J Med. 2016. [Epub ahead of print]. ID - ref74 ER - TY - JOUR AU - Agarwal, R. AU - Aggarwal, A. N. AU - Gupta, D. AU - Jindal, S. K. PY - 2010 DA - 2010// TI - Inhaled corticosteroids vs placebo for preventing COPD exacerbations: a systematic review and metaregression of randomized controlled trials JO - Chest VL - 137 UR - https://doi.org/10.1378/chest.09-1305 DO - 10.1378/chest.09-1305 ID - Agarwal2010 ER - TY - JOUR AU - Oba, Y. AU - Lone, N. A. PY - 2014 DA - 2014// TI - Comparative efficacy of inhaled corticosteroid and long-acting beta agonist combinations in preventing COPD exacerbations: a Bayesian network meta-analysis JO - Int J Chron Obstruct Pulmon Dis VL - 9 UR - https://doi.org/10.2147/COPD.S48492 DO - 10.2147/COPD.S48492 ID - Oba2014 ER - TY - JOUR AU - Nannini, L. J. AU - Poole, P. AU - Milan, S. J. AU - Holmes, R. AU - Normansell, R. PY - 2013 DA - 2013// TI - Combined corticosteroid and long-acting beta2-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease JO - Cochrane Database Syst Rev VL - 11 ID - Nannini2013 ER - TY - JOUR AU - Anzueto, A. AU - Ferguson, G. T. AU - Feldman, G. AU - Chinsky, K. AU - Seibert, A. AU - Emmett, A. AU - Knobil, K. AU - O'Dell, D. AU - Kalberg, C. AU - Crater, G. PY - 2009 DA - 2009// TI - Effect of fluticasone propionate/salmeterol (250/50) on COPD exacerbations and impact on patient outcomes JO - COPD VL - 6 UR - https://doi.org/10.1080/15412550903140881 DO - 10.1080/15412550903140881 ID - Anzueto2009 ER - TY - JOUR AU - Dransfield, M. T. AU - Bourbeau, J. AU - Jones, P. W. AU - Hanania, N. A. AU - Mahler, D. A. AU - Vestbo, J. AU - Wachtel, A. AU - Martinez, F. J. AU - Barnhart, F. AU - Sanford, L. PY - 2013 DA - 2013// TI - Once-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trials JO - Lancet Respir Med VL - 1 UR - https://doi.org/10.1016/S2213-2600(13)70040-7 DO - 10.1016/S2213-2600(13)70040-7 ID - Dransfield2013 ER - TY - JOUR AU - Calverley, P. M. AU - Boonsawat, W. AU - Cseke, Z. AU - Zhong, N. AU - Peterson, S. AU - Olsson, H. PY - 2003 DA - 2003// TI - Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease JO - Eur Respir J VL - 22 UR - https://doi.org/10.1183/09031936.03.00027003 DO - 10.1183/09031936.03.00027003 ID - Calverley2003 ER - TY - JOUR AU - Szafranski, W. AU - Cukier, A. AU - Ramirez, A. AU - Menga, G. AU - Sansores, R. AU - Nahabedian, S. AU - Peterson, S. AU - Olsson, H. PY - 2003 DA - 2003// TI - Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease JO - Eur Respir J VL - 21 UR - https://doi.org/10.1183/09031936.03.00031402 DO - 10.1183/09031936.03.00031402 ID - Szafranski2003 ER - TY - JOUR AU - Agustí, A. AU - Calverley, P. M. AU - Decramer, M. AU - Stockley, R. A. AU - Wedzicha, J. A. PY - 2014 DA - 2014// TI - Prevention of exacerbations in chronic obstructive pulmonary disease: knowns and unknowns JO - J COPD Foundation VL - 1 UR - https://doi.org/10.15326/jcopdf.1.2.2014.0134 DO - 10.15326/jcopdf.1.2.2014.0134 ID - Agustí2014 ER - TY - JOUR AU - DiSantostefano, R. L. AU - Sampson, T. AU - Le, H. V. AU - Hinds, D. AU - Davis, K. J. AU - Bakerly, N. D. PY - 2014 DA - 2014// TI - Risk of pneumonia with inhaled corticosteroid versus long-acting bronchodilator regimens in chronic obstructive pulmonary disease: a new-user cohort study JO - PLoS One VL - 9 UR - https://doi.org/10.1371/journal.pone.0097149 DO - 10.1371/journal.pone.0097149 ID - DiSantostefano2014 ER - TY - JOUR AU - Loke, Y. K. AU - Cavallazzi, R. AU - Singh, S. PY - 2011 DA - 2011// TI - Risk of fractures with inhaled corticosteroids in COPD: systematic review and meta-analysis of randomised controlled trials and observational studies JO - Thorax VL - 66 UR - https://doi.org/10.1136/thx.2011.160028 DO - 10.1136/thx.2011.160028 ID - Loke2011 ER - TY - JOUR AU - Suissa, S. AU - Kezouh, A. AU - Ernst, P. PY - 2010 DA - 2010// TI - Inhaled corticosteroids and the risks of diabetes onset and progression JO - Am J Med VL - 123 UR - https://doi.org/10.1016/j.amjmed.2010.06.019 DO - 10.1016/j.amjmed.2010.06.019 ID - Suissa2010 ER - TY - JOUR AU - Magnussen, H. AU - Disse, B. AU - Rodriguez-Roisin, R. AU - Kirsten, A. AU - Watz, H. AU - Tetzlaff, K. AU - Towse, L. AU - Finnigan, H. AU - Dahl, R. AU - Decramer, M. PY - 2014 DA - 2014// TI - Withdrawal of inhaled glucocorticoids and exacerbations of COPD JO - N Engl J Med VL - 371 UR - https://doi.org/10.1056/NEJMoa1407154 DO - 10.1056/NEJMoa1407154 ID - Magnussen2014 ER - TY - JOUR AU - Nadeem, N. J. AU - Taylor, S. J. AU - Eldridge, S. M. PY - 2011 DA - 2011// TI - Withdrawal of inhaled corticosteroids in individuals with COPD--a systematic review and comment on trial methodology JO - Respir Res VL - 12 UR - https://doi.org/10.1186/1465-9921-12-107 DO - 10.1186/1465-9921-12-107 ID - Nadeem2011 ER - TY - JOUR AU - Rossi, A. AU - Guerriero, M. AU - Corrado, A. PY - 2014 DA - 2014// TI - Withdrawal of inhaled corticosteroids can be safe in COPD patients at low risk of exacerbation: a real-life study on the appropriateness of treatment in moderate COPD patients (OPTIMO) JO - Respir Res VL - 15 ID - Rossi2014 ER - TY - JOUR AU - Rossi, A. AU - Molen, T. AU - Olmo, R. AU - Papi, A. AU - Wehbe, L. AU - Quinn, M. AU - Lu, C. AU - Young, D. AU - Cameron, R. AU - Bucchioni, E. AU - Altman, P. PY - 2014 DA - 2014// TI - INSTEAD: a randomised switch trial of indacaterol versus salmeterol/fluticasone in moderate COPD JO - Eur Respir J VL - 44 UR - https://doi.org/10.1183/09031936.00126814 DO - 10.1183/09031936.00126814 ID - Rossi2014 ER - TY - JOUR AU - Barrecheguren, M. AU - Esquinas, C. AU - Miravitlles, M. PY - 2015 DA - 2015// TI - The asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): opportunities and challenges JO - Curr Opin Pulm Med VL - 21 UR - https://doi.org/10.1097/MCP.0000000000000118 DO - 10.1097/MCP.0000000000000118 ID - Barrecheguren2015 ER - TY - STD TI - Sin DD, Miravitlles M, Mannino DM, Soriano JB, Price D, Celli BR, Leung JM, Nakano Y, Park HY, Wark PA, Wechsler ME. What is asthma-COPD overlap syndrome (ACOS)? Towards a consensus definition from a roundtable discussion. Eur Respir J. 2016;48:664–73. ID - ref91 ER - TY - JOUR AU - Christenson, S. A. AU - Steiling, K. AU - Berge, M. AU - Hijazi, K. AU - Hiemstra, P. S. AU - Postma, D. S. AU - Lenberg, M. E. AU - Spira, A. AU - Woodruff, P. G. PY - 2015 DA - 2015// TI - Asthma-COPD overlap: clinical relevance of genomic signatures of Type 2 inflammation in COPD JO - Am J Respir Crit Care Med VL - 191 UR - https://doi.org/10.1164/rccm.201408-1458OC DO - 10.1164/rccm.201408-1458OC ID - Christenson2015 ER - TY - JOUR AU - Brightling, C. E. AU - McKenna, S. AU - Hargadon, B. AU - Birring, S. AU - Green, R. AU - Siva, R. AU - Berry, M. AU - Parker, D. AU - Monteiro, W. AU - Pavord, I. D. AU - Bradding, P. PY - 2005 DA - 2005// TI - Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease JO - Thorax VL - 60 UR - https://doi.org/10.1136/thx.2004.032516 DO - 10.1136/thx.2004.032516 ID - Brightling2005 ER - TY - JOUR AU - Green, R. H. AU - Brightling, C. E. AU - McKenna, S. AU - Hargadon, B. AU - Parker, D. AU - Bradding, P. AU - Wardlaw, A. J. AU - Pavord, I. D. PY - 2002 DA - 2002// TI - Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial JO - Lancet VL - 360 UR - https://doi.org/10.1016/S0140-6736(02)11679-5 DO - 10.1016/S0140-6736(02)11679-5 ID - Green2002 ER - TY - JOUR AU - Pascoe, S. AU - Locantore, N. AU - Dransfield, M. T. AU - Barnes, N. C. AU - Pavord, I. D. PY - 2015 DA - 2015// TI - Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials JO - Lancet Respir Med VL - 3 UR - https://doi.org/10.1016/S2213-2600(15)00106-X DO - 10.1016/S2213-2600(15)00106-X ID - Pascoe2015 ER - TY - JOUR AU - Siddiqui, S. H. AU - Guasconi, A. AU - Vestbo, J. AU - Jones, P. AU - Agusti, A. AU - Paggiaro, P. AU - Wedzicha, J. A. AU - Singh, D. PY - 2015 DA - 2015// TI - Blood eosinophils: a biomarker of response to extrafine beclomethasone/formoterol in chronic obstructive pulmonary disease JO - Am J Respir Crit Care Med VL - 192 UR - https://doi.org/10.1164/rccm.201502-0235LE DO - 10.1164/rccm.201502-0235LE ID - Siddiqui2015 ER - TY - JOUR AU - Calverley, P. M. AU - Rabe, K. F. AU - Goehring, U. M. AU - Kristiansen, S. AU - Fabbri, L. M. AU - Martinez, F. J. PY - 2009 DA - 2009// TI - Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials JO - Lancet VL - 374 UR - https://doi.org/10.1016/S0140-6736(09)61255-1 DO - 10.1016/S0140-6736(09)61255-1 ID - Calverley2009 ER - TY - JOUR AU - Chong, J. AU - Leung, B. AU - Poole, P. PY - 2013 DA - 2013// TI - Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease JO - Cochrane Database Syst Rev VL - 11 ID - Chong2013 ER - TY - JOUR AU - Martinez, F. J. AU - Calverley, P. M. AU - Goehring, U. M. AU - Brose, M. AU - Fabbri, L. M. AU - Rabe, K. F. PY - 2015 DA - 2015// TI - Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trial JO - Lancet VL - 385 UR - https://doi.org/10.1016/S0140-6736(14)62410-7 DO - 10.1016/S0140-6736(14)62410-7 ID - Martinez2015 ER - TY - JOUR AU - Wedzicha, J. A. AU - Calverley, P. M. AU - Rabe, K. F. PY - 2016 DA - 2016// TI - Roflumilast: a review of its use in the treatment of COPD JO - Int J Chron Obstruct Pulmon Dis VL - 11 UR - https://doi.org/10.2147/COPD.S89849 DO - 10.2147/COPD.S89849 ID - Wedzicha2016 ER - TY - JOUR AU - Michalski, J. M. AU - Golden, G. AU - Ikari, J. AU - Rennard, S. I. PY - 2012 DA - 2012// TI - PDE4: a novel target in the treatment of chronic obstructive pulmonary disease JO - Clin Pharmacol Ther VL - 91 UR - https://doi.org/10.1038/clpt.2011.266 DO - 10.1038/clpt.2011.266 ID - Michalski2012 ER - TY - STD TI - (FDA) FaDA: Daliresp® (roflumilast) tablets [prescribing information]. Oranienburg: Nycomed GmbH; 2011. Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022522s000lbl.pdf. Accessed 27 Aug 2016. UR - http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022522s000lbl.pdf ID - ref102 ER - TY - JOUR AU - Wouters, E. F. AU - Bredenbroker, D. AU - Teichmann, P. AU - Brose, M. AU - Rabe, K. F. AU - Fabbri, L. M. AU - Goke, B. PY - 2012 DA - 2012// TI - Effect of the phosphodiesterase 4 inhibitor roflumilast on glucose metabolism in patients with treatment-naive, newly diagnosed type 2 diabetes mellitus JO - J Clin Endocrinol Metab VL - 97 UR - https://doi.org/10.1210/jc.2011-2886 DO - 10.1210/jc.2011-2886 ID - Wouters2012 ER - TY - JOUR AU - White, W. B. AU - Cooke, G. E. AU - Kowey, P. R. AU - Calverley, P. M. AU - Bredenbroker, D. AU - Goehring, U. M. AU - Zhu, H. AU - Lakkis, H. AU - Mosberg, H. AU - Rowe, P. AU - Rabe, K. F. PY - 2013 DA - 2013// TI - Cardiovascular safety in patients receiving roflumilast for the treatment of COPD JO - Chest VL - 144 UR - https://doi.org/10.1378/chest.12-2332 DO - 10.1378/chest.12-2332 ID - White2013 ER - TY - JOUR AU - Donath, E. AU - Chaudhry, A. AU - Hernandez-Aya, L. F. AU - Lit, L. PY - 2013 DA - 2013// TI - A meta-analysis on the prophylactic use of macrolide antibiotics for the prevention of disease exacerbations in patients with Chronic Obstructive Pulmonary Disease JO - Respir Med VL - 107 UR - https://doi.org/10.1016/j.rmed.2013.05.004 DO - 10.1016/j.rmed.2013.05.004 ID - Donath2013 ER - TY - JOUR AU - Herath, S. C. AU - Poole, P. PY - 2013 DA - 2013// TI - Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD) JO - Cochrane Database Syst Rev VL - 11 ID - Herath2013 ER - TY - JOUR AU - Uzun, S. AU - Djamin, R. S. AU - Kluytmans, J. A. AU - Mulder, P. G. AU - Veer, N. E. AU - Ermens, A. A. AU - Pelle, A. J. AU - Hoogsteden, H. C. AU - Aerts, J. G. AU - Eerden, M. M. PY - 2014 DA - 2014// TI - Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind, placebo-controlled trial JO - Lancet Respir Med VL - 2 UR - https://doi.org/10.1016/S2213-2600(14)70019-0 DO - 10.1016/S2213-2600(14)70019-0 ID - Uzun2014 ER - TY - JOUR AU - Albert, R. K. AU - Connett, J. AU - Bailey, W. C. AU - Casaburi, R. AU - Cooper, J. A. AU - Criner, G. J. AU - Curtis, J. L. AU - Dransfield, M. T. AU - Han, M. K. AU - Lazarus, S. C. PY - 2011 DA - 2011// TI - Azithromycin for prevention of exacerbations of COPD JO - N Engl J Med VL - 365 UR - https://doi.org/10.1056/NEJMoa1104623 DO - 10.1056/NEJMoa1104623 ID - Albert2011 ER - TY - JOUR AU - Miravitlles, M. AU - Anzueto, A. PY - 2015 DA - 2015// TI - Antibiotic prophylaxis in COPD: Why, when, and for whom? JO - Pulm Pharmacol Ther VL - 32 UR - https://doi.org/10.1016/j.pupt.2014.05.002 DO - 10.1016/j.pupt.2014.05.002 ID - Miravitlles2015 ER - TY - JOUR AU - Han, M. K. AU - Tayob, N. AU - Murray, S. AU - Dransfield, M. T. AU - Washko, G. AU - Scanlon, P. D. AU - Criner, G. J. AU - Casaburi, R. AU - Connett, J. AU - Lazarus, S. C. PY - 2014 DA - 2014// TI - Predictors of chronic obstructive pulmonary disease exacerbation reduction in response to daily azithromycin therapy JO - Am J Respir Crit Care Med VL - 189 UR - https://doi.org/10.1164/rccm.201402-0207OC DO - 10.1164/rccm.201402-0207OC ID - Han2014 ER - TY - JOUR AU - Miravitlles, M. PY - 2013 DA - 2013// TI - Long-term antibiotics in COPD: more benefit than harm? JO - Prim Care Respir J VL - 22 UR - https://doi.org/10.4104/pcrj.2013.00074 DO - 10.4104/pcrj.2013.00074 ID - Miravitlles2013 ER - TY - JOUR AU - Poole, P. AU - Black, P. N. AU - Cates, C. J. PY - 2012 DA - 2012// TI - Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease JO - Cochrane Database Syst Rev VL - 8 ID - Poole2012 ER - TY - JOUR AU - Zheng, J. P. AU - Wen, F. Q. AU - Bai, C. X. AU - Wan, H. Y. AU - Kang, J. AU - Chen, P. AU - Yao, W. Z. AU - Ma, L. J. AU - Li, X. AU - Raiteri, L. PY - 2014 DA - 2014// TI - Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial JO - Lancet Respir Med VL - 2 UR - https://doi.org/10.1016/S2213-2600(13)70286-8 DO - 10.1016/S2213-2600(13)70286-8 ID - Zheng2014 ER - TY - JOUR AU - Tse, H. N. AU - Raiteri, L. AU - Wong, K. Y. AU - Ng, L. Y. AU - Yee, K. S. AU - Tseng, C. Z. PY - 2014 DA - 2014// TI - Benefits of high-dose N-acetylcysteine to exacerbation-prone patients with COPD JO - Chest VL - 146 UR - https://doi.org/10.1378/chest.13-2784 DO - 10.1378/chest.13-2784 ID - Tse2014 ER - TY - STD TI - Dal Negro RI, M.; Calverly, P. Efficacy and safety of erdosteine in COPD: Results of a 12-month prospective, multinational study. Presented at the European Respiratory Society Annual Congress 2015; Amsterdam, The Netherlands, 26-30 September 2015 (Abstract PA1495). 2015. ID - ref115 ER - TY - JOUR AU - Mills, E. J. AU - Druyts, E. AU - Ghement, I. AU - Puhan, M. A. PY - 2011 DA - 2011// TI - Pharmacotherapies for chronic obstructive pulmonary disease: a multiple treatment comparison meta-analysis JO - Clin Epidemiol VL - 3 UR - https://doi.org/10.2147/CLEP.S16235 DO - 10.2147/CLEP.S16235 ID - Mills2011 ER - TY - STD TI - Pascoe SJ, Lipson DA, Locantore N, Barnacle H, Brealey N, Mohindra R, Dransfield MT, Pavord I, Barnes N. A phase III randomised controlled trial of single-dose triple therapy in COPD: the IMPACT protocol. Eur Respir J. 2016;48:320-30. ID - ref117 ER - TY - JOUR AU - Brightling, C. E. AU - Bleecker, E. R. AU - Panettieri, R. A. AU - Bafadhel, M. AU - She, D. AU - Ward, C. K. AU - Xu, X. AU - Birrell, C. AU - Merwe, R. PY - 2014 DA - 2014// TI - Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study JO - Lancet Respir Med VL - 2 UR - https://doi.org/10.1016/S2213-2600(14)70187-0 DO - 10.1016/S2213-2600(14)70187-0 ID - Brightling2014 ER - TY - JOUR AU - Fukuchi, Y. AU - Tatsumi, K. AU - Inoue, H. AU - Sakata, Y. AU - Shibata, K. AU - Miyagishi, H. AU - Marukawa, Y. AU - Ichinose, M. PY - 2016 DA - 2016// TI - Prevention of COPD exacerbation by lysozyme: a double-blind, randomized, placebo-controlled study JO - Int J Chron Obstruct Pulmon Dis VL - 11 UR - https://doi.org/10.2147/COPD.S103105 DO - 10.2147/COPD.S103105 ID - Fukuchi2016 ER - TY - STD TI - Cosio BG, Shafiek H, Iglesias A, Yanez A, Cordova R, Palou A, Rodriguez-Roisin R, Peces-Barba G, Pascual S, Gea J, et al. Oral low-dose theophylline on top of inhaled fluticasone-salmeterol does not reduce exacerbations in patients with severe COPD: A pilot clinical trial. Chest. 2016;150:123-130. ID - ref120 ER - TY - STD TI - Watz H, Tetzlaff K, Wouters EF, Kirsten A, Magnussen H, Rodriguez-Roisin R, Vogelmeier C, Fabbri LM, Chanez P, Dahl R, et al. Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial. Lancet Respir Med. 2016: doi:10.1016/S2213-2600(16)00100-4. [Epub ahead of print]. ID - ref121 ER - TY - JOUR AU - Ni, Y. AU - Shi, G. AU - Yu, Y. AU - Hao, J. AU - Chen, T. AU - Song, H. PY - 2015 DA - 2015// TI - Clinical characteristics of patients with chronic obstructive pulmonary disease with comorbid bronchiectasis: a systemic review and meta-analysis JO - Int J Chron Obstruct Pulmon Dis VL - 10 UR - https://doi.org/10.2147/COPD.S83910 DO - 10.2147/COPD.S83910 ID - Ni2015 ER - TY - JOUR AU - Bateman, E. D. AU - Tashkin, D. AU - Siafakas, N. AU - Dahl, R. AU - Towse, L. AU - Massey, D. AU - Pavia, D. AU - Zhong, N. S. PY - 2010 DA - 2010// TI - A one-year trial of tiotropium Respimat plus usual therapy in COPD patients JO - Respir Med VL - 104 UR - https://doi.org/10.1016/j.rmed.2010.06.004 DO - 10.1016/j.rmed.2010.06.004 ID - Bateman2010 ER - TY - JOUR AU - Powrie, D. J. AU - Wilkinson, T. M. AU - Donaldson, G. C. AU - Jones, P. AU - Scrine, K. AU - Viel, K. AU - Kesten, S. AU - Wedzicha, J. A. PY - 2007 DA - 2007// TI - Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD JO - Eur Respir J VL - 30 UR - https://doi.org/10.1183/09031936.00023907 DO - 10.1183/09031936.00023907 ID - Powrie2007 ER - TY - JOUR AU - Dusser, D. AU - Bravo, M. L. AU - Iacono, P. PY - 2006 DA - 2006// TI - The effect of tiotropium on exacerbations and airflow in patients with COPD JO - Eur Respir J VL - 27 UR - https://doi.org/10.1183/09031936.06.00062705 DO - 10.1183/09031936.06.00062705 ID - Dusser2006 ER - TY - JOUR AU - Niewoehner, D. E. AU - Rice, K. AU - Cote, C. AU - Paulson, D. AU - Cooper, J. A. AU - Korducki, L. AU - Cassino, C. AU - Kesten, S. PY - 2005 DA - 2005// TI - Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial JO - Ann Intern Med VL - 143 UR - https://doi.org/10.7326/0003-4819-143-5-200509060-00007 DO - 10.7326/0003-4819-143-5-200509060-00007 ID - Niewoehner2005 ER - TY - JOUR AU - Brusasco, V. AU - Hodder, R. AU - Miravitlles, M. AU - Korducki, L. AU - Towse, L. AU - Kesten, S. PY - 2003 DA - 2003// TI - Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD JO - Thorax VL - 58 UR - https://doi.org/10.1136/thorax.58.5.399 DO - 10.1136/thorax.58.5.399 ID - Brusasco2003 ER - TY - JOUR AU - Vincken, W. AU - Noord, J. A. AU - Greefhorst, A. P. AU - Bantje, T. A. AU - Kesten, S. AU - Korducki, L. AU - Cornelissen, P. J. PY - 2002 DA - 2002// TI - Improved health outcomes in patients with COPD during 1 year’s treatment with tiotropium JO - Eur Respir J VL - 19 UR - https://doi.org/10.1183/09031936.02.00238702 DO - 10.1183/09031936.02.00238702 ID - Vincken2002 ER - TY - JOUR AU - Casaburi, R. AU - Mahler, D. A. AU - Jones, P. W. AU - Wanner, A. AU - San, P. G. AU - ZuWallack, R. L. AU - Menjoge, S. S. AU - Serby, C. W. AU - Witek, T. PY - 2002 DA - 2002// TI - A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease JO - Eur Respir J VL - 19 UR - https://doi.org/10.1183/09031936.02.00269802 DO - 10.1183/09031936.02.00269802 ID - Casaburi2002 ER - TY - JOUR AU - Decramer, M. AU - Anzueto, A. AU - Kerwin, E. AU - Kaelin, T. AU - Richard, N. AU - Crater, G. AU - Tabberer, M. AU - Harris, S. AU - Church, A. PY - 2014 DA - 2014// TI - Efficacy and safety of umeclidinium plus vilanterol versus tiotropium, vilanterol, or umeclidinium monotherapies over 24 weeks in patients with chronic obstructive pulmonary disease: results from two multicentre, blinded, randomised controlled trials JO - Lancet Respir Med VL - 2 UR - https://doi.org/10.1016/S2213-2600(14)70065-7 DO - 10.1016/S2213-2600(14)70065-7 ID - Decramer2014 ER - TY - JOUR AU - Schermer, T. AU - Chavannes, N. AU - Dekhuijzen, R. AU - Wouters, E. AU - Muris, J. AU - Akkermans, R. AU - Schayck, O. AU - Weel, C. PY - 2009 DA - 2009// TI - Fluticasone and N-acetylcysteine in primary care patients with COPD or chronic bronchitis JO - Respir Med VL - 103 UR - https://doi.org/10.1016/j.rmed.2008.11.003 DO - 10.1016/j.rmed.2008.11.003 ID - Schermer2009 ER - TY - JOUR AU - Burge, P. S. AU - Calverley, P. M. AU - Jones, P. W. AU - Spencer, S. AU - Anderson, J. A. AU - Maslen, T. K. PY - 2000 DA - 2000// TI - Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial JO - BMJ VL - 320 UR - https://doi.org/10.1136/bmj.320.7245.1297 DO - 10.1136/bmj.320.7245.1297 ID - Burge2000 ER - TY - JOUR AU - Ohar, J. A. AU - Crater, G. D. AU - Emmett, A. AU - Ferro, T. J. AU - Morris, A. N. AU - Raphiou, I. AU - Sriram, P. S. AU - Dransfield, M. T. PY - 2014 DA - 2014// TI - Fluticasone propionate/salmeterol 250/50 μg versus salmeterol 50 μg after chronic obstructive pulmonary disease exacerbation JO - Respir Res VL - 15 UR - https://doi.org/10.1186/s12931-014-0105-2 DO - 10.1186/s12931-014-0105-2 ID - Ohar2014 ER - TY - JOUR AU - Anzueto, A. AU - Leimer, I. AU - Kesten, S. PY - 2009 DA - 2009// TI - Impact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomes JO - Int J Chron Obstruct Pulmon Dis VL - 4 ID - Anzueto2009 ER - TY - JOUR AU - Ferguson, G. T. AU - Anzueto, A. AU - Fei, R. AU - Emmett, A. AU - Knobil, K. AU - Kalberg, C. PY - 2008 DA - 2008// TI - Effect of fluticasone propionate/salmeterol (250/50 mg) or salmeterol (50 mg) on COPD exacerbations JO - Respir Med VL - 102 UR - https://doi.org/10.1016/j.rmed.2008.04.019 DO - 10.1016/j.rmed.2008.04.019 ID - Ferguson2008 ER - TY - JOUR AU - Seemungal, T. AU - Stockley, R. AU - Calverley, P. AU - Hagan, G. AU - Wedzicha, J. A. PY - 2007 DA - 2007// TI - Investigating new standards for prophylaxis in reduction of exacerbations--the INSPIRE study methodology JO - COPD VL - 4 UR - https://doi.org/10.1080/15412550701407862 DO - 10.1080/15412550701407862 ID - Seemungal2007 ER - TY - JOUR AU - Kardos, P. AU - Wencker, M. AU - Glaab, T. AU - Vogelmeier, C. PY - 2007 DA - 2007// TI - Impact of salmeterol/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease JO - Am J Respir Crit Care Med VL - 175 UR - https://doi.org/10.1164/rccm.200602-244OC DO - 10.1164/rccm.200602-244OC ID - Kardos2007 ER - TY - JOUR AU - Sharafkhaneh, A. AU - Southard, J. G. AU - Goldman, M. AU - Uryniak, T. AU - Martin, U. J. PY - 2012 DA - 2012// TI - Effect of budesonide/formoterol pMDI on COPD exacerbations: a double-blind, randomized study JO - Respir Med VL - 106 UR - https://doi.org/10.1016/j.rmed.2011.07.020 DO - 10.1016/j.rmed.2011.07.020 ID - Sharafkhaneh2012 ER - TY - JOUR AU - Fukuchi, Y. AU - Samoro, R. AU - Fassakhov, R. AU - Taniguchi, H. AU - Ekelund, J. AU - Carlsson, L. G. AU - Ichinose, M. PY - 2013 DA - 2013// TI - Budesonide/formoterol via Turbuhaler(R) versus formoterol via Turbuhaler(R) in patients with moderate to severe chronic obstructive pulmonary disease: phase III multinational study results JO - Respirology VL - 18 UR - https://doi.org/10.1111/resp.12090 DO - 10.1111/resp.12090 ID - Fukuchi2013 ER - TY - JOUR AU - Wedzicha, J. A. AU - Singh, D. AU - Vestbo, J. AU - Paggiaro, P. L. AU - Jones, P. W. AU - Bonnet-Gonod, F. AU - Cohuet, G. AU - Corradi, M. AU - Vezzoli, S. AU - Petruzzelli, S. AU - Agusti, A. PY - 2014 DA - 2014// TI - Extrafine beclomethasone/formoterol in severe COPD patients with history of exacerbations JO - Respir Med VL - 108 UR - https://doi.org/10.1016/j.rmed.2014.05.013 DO - 10.1016/j.rmed.2014.05.013 ID - Wedzicha2014 ER - TY - JOUR AU - Calverley, P. M. AU - Kuna, P. AU - Monsó, E. AU - Costantini, M. AU - Petruzzelli, S. AU - Sergio, F. AU - Varoli, G. AU - Papi, A. AU - Brusasco, V. PY - 2010 DA - 2010// TI - Beclomethasone/formoterol in the management of COPD: a randomised controlled trial JO - Respir Med VL - 104 UR - https://doi.org/10.1016/j.rmed.2010.09.008 DO - 10.1016/j.rmed.2010.09.008 ID - Calverley2010 ER - TY - JOUR AU - Pomares, X. AU - Monton, C. AU - Espasa, M. AU - Casabon, J. AU - Monso, E. AU - Gallego, M. PY - 2011 DA - 2011// TI - Long-term azithromycin therapy in patients with severe COPD and repeated exacerbations JO - Int J Chron Obstruct Pulmon Dis VL - 6 UR - https://doi.org/10.2147/COPD.S23655 DO - 10.2147/COPD.S23655 ID - Pomares2011 ER - TY - JOUR AU - Seemungal, T. A. AU - Wilkinson, T. M. AU - Hurst, J. R. AU - Perera, W. R. AU - Sapsford, R. J. AU - Wedzicha, J. A. PY - 2008 DA - 2008// TI - Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations JO - Am J Respir Crit Care Med VL - 178 UR - https://doi.org/10.1164/rccm.200801-145OC DO - 10.1164/rccm.200801-145OC ID - Seemungal2008 ER - TY - JOUR AU - Zheng, J. P. AU - Kang, J. AU - Huang, S. G. AU - Chen, P. AU - Yao, W. Z. AU - Yang, L. AU - Bai, C. X. AU - Wang, C. Z. AU - Wang, C. AU - Chen, B. Y. PY - 2008 DA - 2008// TI - Effect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study): a randomised placebo-controlled study JO - Lancet VL - 371 UR - https://doi.org/10.1016/S0140-6736(08)60869-7 DO - 10.1016/S0140-6736(08)60869-7 ID - Zheng2008 ER - TY - JOUR AU - Decramer, M. AU - Dekhuijzen, P. N. AU - Troosters, T. AU - Herwaarden, C. AU - Rutten-van Molken, M. AU - Schayck, C. P. AU - Olivieri, D. AU - Lankhorst, I. AU - Ardia, A. PY - 2001 DA - 2001// TI - The Bronchitis Randomized On NAC Cost-Utility Study (BRONCUS): hypothesis and design. BRONCUS-trial Committee JO - Eur Respir J VL - 17 UR - https://doi.org/10.1183/09031936.01.17303290 DO - 10.1183/09031936.01.17303290 ID - Decramer2001 ER - TY - JOUR AU - Decramer, M. AU - Rutten-van Molken, M. AU - Dekhuijzen, P. N. AU - Troosters, T. AU - Herwaarden, C. AU - Pellegrino, R. AU - Schayck, C. P. AU - Olivieri, D. AU - Donno, M. AU - Backer, W. PY - 2005 DA - 2005// TI - Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial JO - Lancet VL - 365 UR - https://doi.org/10.1016/S0140-6736(05)66456-2 DO - 10.1016/S0140-6736(05)66456-2 ID - Decramer2005 ER - TY - JOUR AU - Bateman, E. D. AU - Rabe, K. F. AU - Calverley, P. M. AU - Goehring, U. M. AU - Brose, M. AU - Bredenbroker, D. AU - Fabbri, L. M. PY - 2011 DA - 2011// TI - Roflumilast with long-acting beta2-agonists for COPD: influence of exacerbation history JO - Eur Respir J VL - 38 UR - https://doi.org/10.1183/09031936.00178710 DO - 10.1183/09031936.00178710 ID - Bateman2011 ER - TY - JOUR AU - Calverley, P. M. AU - Sanchez-Toril, F. AU - McIvor, A. AU - Teichmann, P. AU - Bredenbroeker, D. AU - Fabbri, L. M. PY - 2007 DA - 2007// TI - Effect of 1-year treatment with roflumilast in severe chronic obstructive pulmonary disease JO - Am J Respir Crit Care Med VL - 176 UR - https://doi.org/10.1164/rccm.200610-1563OC DO - 10.1164/rccm.200610-1563OC ID - Calverley2007 ER -